A Chinese investor signed Memorandum of Understanding to acquire 45% stake in BioLight Life Sciences Ltd. (TASE:BOLT) from public for ILS 19.4 million on December 6, 2016. Following the acquisition, BioLight will be delisted from the stock exchange. The transaction is subject to due diligence and has been approved by the Board and audit committee of BioLight. As of January 22, 2017, BioLight Life Sciences informs that in light of regulations approved lately by the Chinese government regarding investments outside China, which are pending for implementation at a yet unknown date, the Fund cannot carry out the investment at the moment.